Correction to “The thymocyte-specific RNA-binding protein Arpp21 provides TCR repertoire diversity by binding to the 3’-UTR and promoting Rag1 mRNA expression”

• Meng Xu,
• Taku Ito-Kureha,
• Hyun-Seo Kang,
• Aleksandar Chernev,
• Timsse Raj,
• Kai P. Hoefig,
• Christine Hohn,
• Florian Giesert,
• Yinhu Wang,
• Wenliang Pan,
• Natalia Ziętara,
• Tobias Straub,
• Regina Feederle,
• Carolin Daniel,
• Barbara Adler,
• Julian König,
• Stefan Feske,
• George C. Tsokos,
• Wolfgang Wurst,
• Henning Urlaub,
• Michael Sattler,
• Jan Kisielow,
• F. Gregory Wulczyn,
• Marcin Łyszkiewicz,
• Vigo Heissmeyer

Affiliations

Meng Xu

Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München

Taku Ito-Kureha

Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich

Hyun-Seo Kang

Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München

Aleksandar Chernev

Max Planck Institute for Multidisciplinary Sciences, Bioanalytical Mass Spectrometry

Timsse Raj

Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich

Kai P. Hoefig

Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München

Christine Hohn

Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich

Florian Giesert

Institute of Developmental Genetics, Helmholtz Zentrum München

Yinhu Wang

Department of Pathology, New York University, Grossman School of Medicine

Wenliang Pan

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School

Natalia Ziętara

Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich

Tobias Straub

Institute for Molecular Biology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich

Regina Feederle

Monoclonal Antibody Core Facility, German Research Center for Environmental Health

Carolin Daniel

Research Unit Type 1 Diabetes Immunology, Helmholtz Diabetes Center at Helmholtz Zentrum München

Barbara Adler

Max von Pettenkofer Institute, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich

Julian König

Institute of Molecular Biology (IMB)

Stefan Feske

Department of Pathology, New York University, Grossman School of Medicine

George C. Tsokos

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School

Wolfgang Wurst

Institute of Developmental Genetics, Helmholtz Zentrum München

Henning Urlaub

Max Planck Institute for Multidisciplinary Sciences, Bioanalytical Mass Spectrometry

Michael Sattler

Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München

Jan Kisielow

Institute for Molecular Health Sciences, ETH Zürich

F. Gregory Wulczyn

Institute for Integrative Neuroanatomie, Charite-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health

Marcin Łyszkiewicz

Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München

Vigo Heissmeyer

Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München